Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Aerovate Therapeutics, Inc.US flagNASDAQ Global Market
2.68
USD
- -
- -
77.68MMarket Cap

Aerovate Therapeutics, Inc. (AVTE) Stock Split History

Learn about Aerovate Therapeutics, Inc.'s most recent 1-for-35 basis stock split on April 29, 2025. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Aerovate Therapeutics, Inc.'s most recent stock split

Split Date: 2025-04-29
Split Ratio: 1:35
Price Before Split: $2.68
Price After Split: $0.08

Developer API

Get AVTE split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/AVTE

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 35.00 times fewer shares (a 1:35 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Aerovate Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-04-291:35Yes$2.68$0.08

About Aerovate Therapeutics, Inc.

Company overview and industry information

Aerovate Therapeutics, Inc. (AVTE) operates in the Biotechnology industry. The recent 1-for-35 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Aerovate Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.